Kim Tae-Don相关文献与解析，生知库 | 链接生命科学的每一步

Jo Seona, Lee Yu Bin, Kim Seok Min, Lee Soo Yun, Choi Myeongjin, Kyun Mi-Lang, Jeong Seo Yule, Lee Sunyoung, Kim Ji Hyun, Kim Yoonji, Kim Yu Jung, Park Sora, Moon Kyoung-Sik, Kim Tae-Don

细胞生物学

CD5

NK 细胞

CAR-NK

发表日期：2025

文献求助收藏

Developing CAR-T/NK cells that target EphA2 for non-small cell lung cancer treatment.

开发靶向 EphA2 的 CAR-T/NK 细胞用于非小细胞肺癌治疗

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1448438

Kim Seok Min, Lee Soo Yun, Kim Seo In, Bae Ji Yeong, Hong Jin Tae, Jo Seona, Kim Ji Hyun, Chung Hyo-Young, Kim Tae-Don

Therapeutic potential of anti-ErbB3 chimeric antigen receptor natural killer cells against breast cancer

抗ErbB3嵌合抗原受体自然杀伤细胞治疗乳腺癌的潜力

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-024-03923-y

Lee, Juheon; Song, Jinhoo; Yoo, Wonbeak; Choi, Hyunji; Jung, Dana; Choi, Eunjeong; Jo, Seo-Gyeong; Gong, Eun-Yeung; Jeoung, Young-Hee; Park, You-Soo; Son, Woo-Chang; Lee, Hosuk; Lee, Hayoung; Kim, Jeom Ji; Kim, TaeEun; Lee, Sooyun; Park, Jang-June; Kim, Tae-Don; Kim, Seok-Ho

Microfluidics-assisted fabrication of natural killer cell-laden microgel enhances the therapeutic efficacy for tumor immunotherapy

微流控技术辅助制备负载自然杀伤细胞的微凝胶可增强肿瘤免疫疗法的疗效。

期刊:Materials Today Bio

影响因子:10.2

doi:10.1016/j.mtbio.2024.101055

Lee, Dongjin; Kim, Seok Min; Kim, Dahong; Baek, Seung Yeop; Yeo, Seon Ju; Lee, Jae Jong; Cha, Chaenyung; Park, Su A; Kim, Tae-Don

B7H6 is the predominant activating ligand driving natural killer cell-mediated killing in patients with liquid tumours: evidence from clinical, in silico, in vitro, and in vivo studies

B7H6是驱动血液肿瘤患者自然杀伤细胞介导杀伤作用的主要激活配体：来自临床、计算机模拟、体外和体内研究的证据

期刊:EBioMedicine

影响因子:9.7

doi:10.1016/j.ebiom.2024.105459

Sunyoung Lee ，Seok Joo Chae ，In-Hwan Jang ，Se-Chan Oh ，Seok-Min Kim ，Soo Yun Lee ，Ji Hyun Kim ，Jesang Ko ，Hang J Kim ，Ik-Chan Song ，Jae Kyoung Kim ，Tae-Don Kim

Harnessing B7-H6 for Anticancer Immunotherapy: Expression, Pathways, and Therapeutic Strategies

利用B7-H6进行抗癌免疫治疗：表达、通路和治疗策略

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms251910326

Lee, Sunyoung; Kim, Ji Hyun; Jang, In-Hwan; Jo, Seona; Lee, Soo Yun; Oh, Se-Chan; Kim, Seok-Min; Kong, Lingzu; Ko, Jesang; Kim, Tae-Don

Understanding nucleic acid sensing and its therapeutic applications

了解核酸传感及其治疗应用

期刊:Experimental and Molecular Medicine

影响因子:12.9

doi:10.1038/s12276-023-01118-6

Kong, Ling-Zu; Kim, Seok-Min; Wang, Chunli; Lee, Soo Yun; Oh, Se-Chan; Lee, Sunyoung; Jo, Seona; Kim, Tae-Don

发表日期：2023

文献求助收藏

Breakthroughs in Cancer Immunotherapy: An Overview of T Cell, NK Cell, Mφ, and DC-Based Treatments

癌症免疫疗法的突破：T细胞、NK细胞、巨噬细胞和树突状细胞疗法概述

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms242417634

Lee, Sunyoung; Kim, Tae-Don

Enhancement of NK cell activity via DNA-sensing inhibition by Poxin transgene

Poxin转基因通过抑制DNA感应增强NK细胞活性

IL-7Rα signaling potentiates the anti-tumor activity of NK92 cells

IL-7Rα信号通路增强NK92细胞的抗肿瘤活性

Fine-tuning signal strength in CD5 CAR-NK cells for targeted T cell cancer therapy.

微调 CD5 CAR-NK 细胞中的信号强度以进行靶向 T 细胞癌症治疗。

Developing CAR-T/NK cells that target EphA2 for non-small cell lung cancer treatment.

开发靶向 EphA2 的 CAR-T/NK 细胞用于非小细胞肺癌治疗

Therapeutic potential of anti-ErbB3 chimeric antigen receptor natural killer cells against breast cancer

抗ErbB3嵌合抗原受体自然杀伤细胞治疗乳腺癌的潜力

Microfluidics-assisted fabrication of natural killer cell-laden microgel enhances the therapeutic efficacy for tumor immunotherapy

微流控技术辅助制备负载自然杀伤细胞的微凝胶可增强肿瘤免疫疗法的疗效。

B7H6 is the predominant activating ligand driving natural killer cell-mediated killing in patients with liquid tumours: evidence from clinical, in silico, in vitro, and in vivo studies

B7H6是驱动血液肿瘤患者自然杀伤细胞介导杀伤作用的主要激活配体：来自临床、计算机模拟、体外和体内研究的证据

Harnessing B7-H6 for Anticancer Immunotherapy: Expression, Pathways, and Therapeutic Strategies

利用B7-H6进行抗癌免疫治疗：表达、通路和治疗策略

Understanding nucleic acid sensing and its therapeutic applications

了解核酸传感及其治疗应用

Breakthroughs in Cancer Immunotherapy: An Overview of T Cell, NK Cell, Mφ, and DC-Based Treatments

癌症免疫疗法的突破：T细胞、NK细胞、巨噬细胞和树突状细胞疗法概述